Burning Rock Biotech (BNR) Receivables - Other (2020 - 2024)
Historic Receivables - Other for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $1.8 million.
- Burning Rock Biotech's Receivables - Other fell 2752.08% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 2752.08%. This contributed to the annual value of $1.9 million for FY2024, which is 4076.15% down from last year.
- Burning Rock Biotech's Receivables - Other amounted to $1.8 million in Q3 2025, which was down 2752.08% from $2.1 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Receivables - Other ranged from a high of $8.1 million in Q2 2023 and a low of $1.8 million during Q3 2025
- Moreover, its 5-year median value for Receivables - Other was $4.6 million (2022), whereas its average is $4.7 million.
- Per our database at Business Quant, Burning Rock Biotech's Receivables - Other soared by 2068750.0% in 2021 and then tumbled by 6835.98% in 2024.
- Burning Rock Biotech's Receivables - Other (Quarter) stood at $6.7 million in 2021, then decreased by 8.99% to $6.1 million in 2022, then plummeted by 47.08% to $3.2 million in 2023, then plummeted by 40.76% to $1.9 million in 2024, then decreased by 3.42% to $1.8 million in 2025.
- Its Receivables - Other stands at $1.8 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.4 million for Q1 2025.